Rydar Equities’s Amgen AMGN Stock Holding History

Rydar Equities’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$114K	Buy	+277	New	+$110K	0.06%	134

Other funds holding AMGN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Rydar Equities's AMGN Position: Q3 2026 in Review

Rydar Equities opened a new position in Amgen (AMGN) in Q3 2026: 277 shares worth $114K. The stake represents 0.06% of the portfolio and ranks #134 among its holdings.

704 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Rydar Equities held 277 shares of Amgen worth $114K as of Q3 2026.
Amgen was a new Rydar Equities position in Q3 2026.
Amgen made up 0.06% of Rydar Equities's portfolio in Q3 2026, its #134 holding.
704 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.